Hidekazu Tachibana

Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab

Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo et al. · Urologic Oncology Seminars and Original Investigations · 2019 · 95 citations

Urology, Cancer Immunosurveillance, Genitourinary Cancer +6

Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma

Hiroki Ishihara, Hidekazu Tachibana, Toshio Takagi et al. · Targeted Oncology · 2019 · 66 citations

Nivolumab Therapy, Prognostic Biomarkers, Urology +7

Robot‐assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: A propensity score‐matched comparative analysis of surgical outcomes

Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana et al. · International Journal of Urology · 2017 · 37 citations · Full text

Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era

Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 30 citations

Urology, Surgical Oncology, Prognostic Impact +9

A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes

Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana et al. · International Urology and Nephrology · 2016 · 29 citations

Laparoscopy, Surgical Oncology, Urology +9